Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 63
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for NTLA

Stock Name	Intellia Therapeutics Inc
Ticker	NTLA(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US45826J1051
LEI	5493002T5BCPE5DZC723

Show aggregate NTLA holdings

News associated with NTLA

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Sold by Mariner LLC: Mariner LLC decreased its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 14.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 14,820 shares of the company’s stock after selling 2,496 shares during the quarter. Mariner LLC’s holdings in Intellia Therapeutics were worth […] - 2025-05-08 07:38:44
Dimensional Fund Advisors LP Purchases 528,962 Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA): Dimensional Fund Advisors LP increased its position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 36.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,976,212 shares of the company’s stock after purchasing an additional 528,962 shares during the quarter. […] - 2025-05-07 08:26:54
MetLife Investment Management LLC Buys 3,491 Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA): MetLife Investment Management LLC boosted its stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 6.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 59,187 shares of the company’s stock after purchasing an additional 3,491 shares during the period. […] - 2025-05-05 08:22:56
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought: Cathie Wood's investing style is bouncing back into fancy. The co-founder, CEO, and investment manager of Ark Invest is winning again. Her most popular exchange-traded fund has risen 6% over the past month, a welcome contrast to the flat overall market in that time. Her 14% retur - 2025-04-30 14:15:00
Renaissance Technologies LLC Makes New $1.15 Million Investment in Intellia Therapeutics, Inc. (NASDAQ:NTLA): Renaissance Technologies LLC acquired a new position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 98,700 shares of the company’s stock, valued at approximately $1,151,000. Several other institutional investors have also recently […] - 2025-04-30 08:40:57
Marshall Wace LLP Makes New Investment in Intellia Therapeutics, Inc. (NASDAQ:NTLA): Marshall Wace LLP purchased a new stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 95,339 shares of the company’s stock, valued at approximately $1,112,000. Several other large investors also recently made […] - 2025-04-30 07:59:02
Barclays PLC Has $3.63 Million Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA): Barclays PLC boosted its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 6.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 311,632 shares of the company’s stock after buying an additional 18,837 shares during the period. Barclays PLC owned approximately 0.31% […] - 2025-04-29 08:19:03
Sterling Capital Management LLC Raises Stock Holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA): Sterling Capital Management LLC lifted its holdings in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 866.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,198 shares of the company’s stock after acquiring an additional 2,867 shares […] - 2025-04-25 08:34:52
Wells Fargo & Company MN Increases Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA): Wells Fargo & Company MN increased its stake in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 38.3% in the fourth quarter, HoldingsChannel reports. The firm owned 277,692 shares of the company’s stock after buying an additional 76,872 shares during the period. Wells Fargo & Company MN’s holdings in Intellia Therapeutics were worth […] - 2025-04-23 07:34:49
XTX Topco Ltd Increases Stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA): XTX Topco Ltd grew its position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 194.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 43,908 shares of the company’s stock after acquiring an additional 29,006 shares during the period. XTX Topco Ltd’s holdings in […] - 2025-04-21 09:10:48
Rockefeller Capital Management L.P. Increases Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA): Rockefeller Capital Management L.P. boosted its position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 81.3% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 137,838 shares of the company’s stock after acquiring an additional 61,800 shares during the period. Rockefeller Capital Management L.P.’s holdings in Intellia […] - 2025-04-21 08:26:43
Schroder Investment Management Group Has $274,000 Stock Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA): Schroder Investment Management Group lessened its position in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 72.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 24,000 shares of the company’s stock after selling 61,999 shares during the quarter. Schroder Investment Management […] - 2025-04-09 08:12:51
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Acquired by Mitsubishi UFJ Asset Management Co. Ltd.: Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 67.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 17,293 shares of the company’s stock after acquiring an additional 6,972 shares during the quarter. Mitsubishi […] - 2025-04-04 08:12:58
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Sold by HighTower Advisors LLC: HighTower Advisors LLC lowered its stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 22.9% in the 4th quarter, HoldingsChannel.com reports. The firm owned 15,639 shares of the company’s stock after selling 4,639 shares during the quarter. HighTower Advisors LLC’s holdings in Intellia Therapeutics were worth $182,000 at the end of the most recent […] - 2025-04-04 07:24:50
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Purchased by Intech Investment Management LLC: Intech Investment Management LLC increased its stake in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 22.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 34,544 shares of the company’s stock after buying an additional 6,341 shares during the quarter. Intech […] - 2025-03-26 08:20:51
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought: The last few weeks of cascading share prices may be troublesome to most investors, but Cathie Wood doesn't mind buying during the deluge. The co-founder, CEO, and investment manager at Ark Invest has been more active lately in buying shares for her high-octane growth exchange-tra - 2025-03-21 15:25:00
Amundi Trims Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA): Amundi decreased its position in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 19.7% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 48,795 shares of the company’s stock after selling 11,987 shares during the quarter. Amundi’s holdings in Intellia Therapeutics were worth $587,000 at the end of the most recent quarter. […] - 2025-03-21 07:53:05
Bank of New York Mellon Corp Cuts Stock Holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA): Bank of New York Mellon Corp reduced its position in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 1.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 284,614 shares of the company’s stock after selling 3,730 shares […] - 2025-03-20 07:13:00
Wealthfront Advisers LLC Acquires New Shares in Intellia Therapeutics, Inc. (NASDAQ:NTLA): Wealthfront Advisers LLC acquired a new stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 22,525 shares of the company’s stock, valued at approximately $263,000. Other large investors have also recently added to or […] - 2025-03-18 08:25:03
Daiwa Securities Group Inc. Boosts Stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA): Daiwa Securities Group Inc. grew its stake in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 80.6% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 5,151 shares of the company’s stock after buying an additional 2,299 shares during the quarter. […] - 2025-03-18 07:43:01
Intellia Therapeutics (NASDAQ:NTLA) Price Target Cut to $50.00 by Analysts at Truist Financial: Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) had its price objective dropped by equities researchers at Truist Financial from $90.00 to $50.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Truist Financial’s price objective would indicate a potential upside of 434.19% from the company’s previous close. […] - 2025-03-06 08:37:46
Intellia Therapeutics (NASDAQ:NTLA) Sets New 12-Month Low After Analyst Downgrade: Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report)’s share price hit a new 52-week low during trading on Tuesday after Truist Financial lowered their price target on the stock from $90.00 to $50.00. Truist Financial currently has a buy rating on the stock. Intellia Therapeutics traded as low as $8.36 and last traded at $8.58, […] - 2025-03-06 06:29:12
Y Intercept Hong Kong Ltd Makes New $304,000 Investment in Intellia Therapeutics, Inc. (NASDAQ:NTLA): Y Intercept Hong Kong Ltd acquired a new stake in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 26,071 shares of the company’s stock, valued at approximately $304,000. Several other hedge funds and […] - 2025-03-05 10:19:00
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Bought by Handelsbanken Fonder AB: Handelsbanken Fonder AB lifted its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 7.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 34,700 shares of the company’s stock after acquiring an additional 2,300 shares during the period. Handelsbanken Fonder […] - 2025-03-03 09:35:19
D.A. Davidson & CO. Lowers Stock Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA): D.A. Davidson & CO. decreased its holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 9.1% in the 4th quarter, Holdings Channel reports. The firm owned 14,770 shares of the company’s stock after selling 1,480 shares during the period. D.A. Davidson & CO.’s holdings in Intellia Therapeutics were worth $172,000 as of its most […] - 2025-02-28 08:46:50
Brokerages Set Intellia Therapeutics, Inc. (NASDAQ:NTLA) Price Target at $48.71: Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the eighteen ratings firms that are presently covering the company, MarketBeat.com reports. Six analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to […] - 2025-02-27 06:09:05

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) NTLA holdings

Date	Number of NTLA Shares Held	Base Market Value of NTLA Shares	Local Market Value of NTLA Shares	Change in NTLA Shares Held	Change in NTLA Base Value	Current Price per NTLA Share Held	Previous Price per NTLA Share Held
2025-05-08 (Thursday)	48,479	USD 401,406	USD 401,406	0	USD 47,994	USD 8.28	USD 7.29
2025-05-07 (Wednesday)	48,479	USD 353,412	USD 353,412	0	USD 1,939	USD 7.29	USD 7.25001
2025-05-06 (Tuesday)	48,479	USD 351,473	USD 351,473	0	USD -57,690	USD 7.25001	USD 8.44001
2025-05-05 (Monday)	48,479	USD 409,163	USD 409,163	0	USD -19,391	USD 8.44001	USD 8.83999
2025-05-02 (Friday)	48,479	USD 428,554	USD 428,554	0	USD 9,695	USD 8.83999	USD 8.64001
2025-05-01 (Thursday)	48,479	USD 418,859	USD 418,859	0	USD -11,150	USD 8.64001	USD 8.87001
2025-04-30 (Wednesday)	48,479	USD 430,009	USD 430,009	0	USD 32,481	USD 8.87001	USD 8.2
2025-04-29 (Tuesday)	48,479	USD 397,528	USD 397,528	0	USD -13,574	USD 8.2	USD 8.48
2025-04-28 (Monday)	48,479	USD 411,102	USD 411,102	0	USD 8,242	USD 8.48	USD 8.30999
2025-04-25 (Friday)	48,479	USD 402,860	USD 402,860	0	USD 6,302	USD 8.30999	USD 8.18
2025-04-24 (Thursday)	48,479	USD 396,558	USD 396,558	0	USD 4,363	USD 8.18	USD 8.09
2025-04-23 (Wednesday)	48,479	USD 392,195	USD 392,195	172	USD -9,236	USD 8.09	USD 8.31
2025-04-22 (Tuesday)	48,307	USD 401,431	USD 401,431	0	USD 18,840	USD 8.31	USD 7.91999
2025-04-21 (Monday)	48,307	USD 382,591	USD 382,591	0	USD 33,331	USD 7.91999	USD 7.23001
2025-04-18 (Friday)	48,307	USD 349,260	USD 349,260	0	USD 0	USD 7.23001	USD 7.23001
2025-04-17 (Thursday)	48,307	USD 349,260	USD 349,260	0	USD 17,874	USD 7.23001	USD 6.86
2025-04-16 (Wednesday)	48,307	USD 331,386	USD 331,386	0	USD -24,154	USD 6.86	USD 7.36001
2025-04-15 (Tuesday)	48,307	USD 355,540	USD 355,540	0	USD -6,763	USD 7.36001	USD 7.50001
2025-04-14 (Monday)	48,307	USD 362,303	USD 362,303	0	USD 4,348	USD 7.50001	USD 7.41
2025-04-11 (Friday)	48,307	USD 357,955	USD 357,955	0	USD 30,917	USD 7.41	USD 6.76999
2025-04-10 (Thursday)	48,307	USD 327,038	USD 327,038	-1,376	USD -24,718	USD 6.76999	USD 7.08001
2025-04-09 (Wednesday)	49,683	USD 351,756	USD 351,756	0	USD 39,747	USD 7.08001	USD 6.27999
2025-04-08 (Tuesday)	49,683	USD 312,009	USD 312,009	-172	USD -14,043	USD 6.27999	USD 6.54001
2025-04-07 (Monday)	49,855	USD 326,052	USD 326,052	-172	USD -5,627	USD 6.54001	USD 6.63
2025-04-04 (Friday)	50,027	USD 331,679	USD 331,679	-865	USD -39,833	USD 6.63	USD 7.30001
2025-04-02 (Wednesday)	50,892	USD 371,512	USD 371,512	0	USD 32,826	USD 7.30001	USD 6.65499
2025-04-01 (Tuesday)	50,892	USD 338,686	USD 338,686	708	USD -18,122	USD 6.65499	USD 7.11
2025-03-31 (Monday)	50,184	USD 356,808	USD 356,808	-519	USD -52,365	USD 7.11	USD 8.07
2025-03-28 (Friday)	50,703	USD 409,173	USD 409,173	0	USD -16,732	USD 8.07	USD 8.4
2025-03-27 (Thursday)	50,703	USD 425,905	USD 425,905	0	USD 4,563	USD 8.4	USD 8.31
2025-03-26 (Wednesday)	50,703	USD 421,342	USD 421,342	0	USD -21,295	USD 8.31	USD 8.73
2025-03-25 (Tuesday)	50,703	USD 442,637	USD 442,637	0	USD -29,408	USD 8.73	USD 9.31
2025-03-24 (Monday)	50,703	USD 472,045	USD 472,045	0	USD 15,718	USD 9.31	USD 9
2025-03-21 (Friday)	50,703	USD 456,327	USD 456,327	3,042	USD 41,676	USD 9	USD 8.70001
2025-03-20 (Thursday)	47,661	USD 414,651	USD 414,651	0	USD -28,596	USD 8.70001	USD 9.29999
2025-03-19 (Wednesday)	47,661	USD 443,247	USD 443,247	0	USD 5,242	USD 9.29999	USD 9.19001
2025-03-18 (Tuesday)	47,661	USD 438,005	USD 438,005	0	USD -18,587	USD 9.19001	USD 9.57999
2025-03-17 (Monday)	47,661	USD 456,592	USD 456,592	0	USD 20,970	USD 9.57999	USD 9.14001
2025-03-14 (Friday)	47,661	USD 435,622	USD 435,622	-2,624	USD -28,006	USD 9.14001	USD 9.22001
2025-03-13 (Thursday)	50,285	USD 463,628	USD 463,628	0	USD -20,114	USD 9.22001	USD 9.62001
2025-03-12 (Wednesday)	50,285	USD 483,742	USD 483,742	0	USD 16,091	USD 9.62001	USD 9.30001
2025-03-11 (Tuesday)	50,285	USD 467,651	USD 467,651	0	USD -8,045	USD 9.30001	USD 9.46
2025-03-10 (Monday)	50,285	USD 475,696	USD 475,696	0	USD -44,754	USD 9.46	USD 10.35
2025-03-07 (Friday)	50,285	USD 520,450	USD 520,450	-326	USD 19,401	USD 10.35	USD 9.9
2025-03-06 (Thursday)	50,611	USD 501,049	USD 501,049	0	USD 27,077	USD 9.9	USD 9.365
2025-03-05 (Wednesday)	50,611	USD 473,972	USD 473,972	0	USD 13,665	USD 9.365	USD 9.095
2025-03-04 (Tuesday)	50,611	USD 460,307	USD 460,307	-163	USD -19,507	USD 9.095	USD 9.44999
2025-03-03 (Monday)	50,774	USD 479,814	USD 479,814	0	USD -32,496	USD 9.44999	USD 10.09
2025-02-28 (Friday)	50,774	USD 512,310	USD 512,310	0	USD -39,096	USD 10.09	USD 10.86
2025-02-27 (Thursday)	50,774	USD 551,406	USD 551,406	0	USD 3,047	USD 10.86	USD 10.8
2025-02-26 (Wednesday)	50,774	USD 548,359	USD 548,359	0	USD 4,569	USD 10.8	USD 10.71
2025-02-25 (Tuesday)	50,774	USD 543,790	USD 543,790	326	USD -36,866	USD 10.71	USD 11.51
2025-02-24 (Monday)	50,448	USD 580,656	USD 580,656	0	USD -33,296	USD 11.51	USD 12.17
2025-02-21 (Friday)	50,448	USD 613,952	USD 613,952	0	USD -4,036	USD 12.17	USD 12.25
2025-02-20 (Thursday)	50,448	USD 617,988	USD 617,988	0	USD -1,513	USD 12.25	USD 12.28
2025-02-19 (Wednesday)	50,448	USD 619,501	USD 619,501	-162	USD 35,968	USD 12.28	USD 11.53
2025-02-18 (Tuesday)	50,610	USD 583,533	USD 583,533	0	USD 42,006	USD 11.53	USD 10.7
2025-02-17 (Monday)	50,610	USD 541,527	USD 541,527	0	USD 0	USD 10.7	USD 10.7
2025-02-14 (Friday)	50,610	USD 541,527	USD 541,527	0	USD 53,647	USD 10.7	USD 9.63999
2025-02-13 (Thursday)	50,610	USD 487,880	USD 487,880	486	USD 11,201	USD 9.63999	USD 9.51
2025-02-12 (Wednesday)	50,124	USD 476,679	USD 476,679	162	USD 16,529	USD 9.51	USD 9.21
2025-02-11 (Tuesday)	49,962	USD 460,150	USD 460,150	648	USD -12,278	USD 9.21	USD 9.58
2025-02-10 (Monday)	49,314	USD 472,428	USD 472,428	0	USD -10,356	USD 9.58	USD 9.79
2025-02-07 (Friday)	49,314	USD 482,784	USD 482,784	0	USD -16,767	USD 9.79	USD 10.13
2025-02-06 (Thursday)	49,314	USD 499,551	USD 499,551	0	USD -18,739	USD 10.13	USD 10.51
2025-02-05 (Wednesday)	49,314	USD 518,290	USD 518,290	0	USD 43,889	USD 10.51	USD 9.62001
2025-02-04 (Tuesday)	49,314	USD 474,401	USD 474,401	0	USD 3,945	USD 9.62001	USD 9.54001
2025-02-03 (Monday)	49,314	USD 470,456	USD 470,456	0	USD -38,464	USD 9.54001	USD 10.32
2025-01-31 (Friday)	49,314	USD 508,920	USD 508,920	0	USD -9,370	USD 10.32	USD 10.51
2025-01-30 (Thursday)	49,314	USD 518,290	USD 518,290	0	USD 19,232	USD 10.51	USD 10.12
2025-01-29 (Wednesday)	49,314	USD 499,058	USD 499,058	0	USD 5,425	USD 10.12	USD 10.01
2025-01-28 (Tuesday)	49,314	USD 493,633	USD 493,633	0	USD -26,630	USD 10.01	USD 10.55
2025-01-27 (Monday)	49,314	USD 520,263	USD 520,263	0	USD -21,698	USD 10.55	USD 10.99
2025-01-24 (Friday)	49,314	USD 541,961	USD 541,961	0	USD -14,794	USD 10.99	USD 11.29
2025-01-23 (Thursday)	49,314	USD 556,755	USD 556,755	0	USD 13,808	USD 11.29	USD 11.01
2025-01-22 (Wednesday)	49,314	USD 542,947	USD 542,947
2025-01-21 (Tuesday)	49,314	USD 490,181	USD 490,181
2025-01-20 (Monday)	49,314	USD 468,483	USD 468,483
2025-01-17 (Friday)	49,314	USD 468,483	USD 468,483
2025-01-16 (Thursday)	48,666	USD 458,434	USD 458,434
2025-01-15 (Wednesday)	48,018	USD 466,255	USD 466,255
2025-01-14 (Tuesday)	48,018	USD 467,455	USD 467,455
2025-01-13 (Monday)	48,018	USD 482,581	USD 482,581
2025-01-10 (Friday)	48,018	USD 489,784	USD 489,784
2025-01-09 (Thursday)	48,340	USD 581,047	USD 581,047
2025-01-09 (Thursday)	48,340	USD 581,047	USD 581,047
2025-01-09 (Thursday)	48,340	USD 581,047	USD 581,047
2025-01-08 (Wednesday)	48,340	USD 581,047	USD 581,047
2025-01-08 (Wednesday)	48,340	USD 581,047	USD 581,047
2025-01-08 (Wednesday)	48,340	USD 581,047	USD 581,047
2025-01-02 (Thursday)	48,984	USD 598,584	USD 598,584	0	USD 39,677	USD 12.22	USD 11.41
2024-12-30 (Monday)	48,984	USD 558,907	USD 558,907	-5,493	USD -242,994	USD 11.41	USD 14.72
2024-12-10 (Tuesday)	54,477	USD 801,901	USD 801,901	0	USD 5,447	USD 14.72	USD 14.62
2024-12-09 (Monday)	54,477	USD 796,454	USD 796,454	0	USD -5,447	USD 14.62	USD 14.72
2024-12-06 (Friday)	54,477	USD 801,901	USD 801,901	0	USD 58,290	USD 14.72	USD 13.65
2024-12-05 (Thursday)	54,477	USD 743,611	USD 743,611	0	USD -45,761	USD 13.65	USD 14.49
2024-12-04 (Wednesday)	54,477	USD 789,372	USD 789,372	0	USD -8,716	USD 14.49	USD 14.65
2024-12-03 (Tuesday)	54,477	USD 798,088	USD 798,088	0	USD -58,835	USD 14.65	USD 15.73
2024-12-02 (Monday)	54,477	USD 856,923	USD 856,923	0	USD 5,992	USD 15.73	USD 15.62
2024-11-29 (Friday)	54,477	USD 850,931	USD 850,931	0	USD 22,336	USD 15.62	USD 15.21
2024-11-28 (Thursday)	54,477	USD 828,595	USD 828,595	0	USD 0	USD 15.21	USD 15.21
2024-11-27 (Wednesday)	54,477	USD 828,595	USD 828,595	0	USD 26,149	USD 15.21	USD 14.73
2024-11-26 (Tuesday)	54,477	USD 802,446	USD 802,446	0	USD -3,269	USD 14.73	USD 14.79
2024-11-25 (Monday)	54,477	USD 805,715	USD 805,715	0	USD 26,694	USD 14.79	USD 14.3
2024-11-22 (Friday)	54,477	USD 779,021	USD 779,021	0	USD 27,238	USD 14.3	USD 13.8
2024-11-21 (Thursday)	54,477	USD 751,783	USD 751,783	0	USD 37,045	USD 13.8	USD 13.12
2024-11-20 (Wednesday)	54,477	USD 714,738	USD 714,738	0	USD -55,022	USD 13.12	USD 14.13
2024-11-19 (Tuesday)	54,477	USD 769,760	USD 769,760	0	USD -2,179	USD 14.13	USD 14.17
2024-11-18 (Monday)	54,477	USD 771,939	USD 771,939	-2,625	USD -178,809	USD 14.17	USD 16.65
2024-11-12 (Tuesday)	57,102	USD 950,748	USD 950,748	0	USD -4,568	USD 16.65	USD 16.73
2024-11-08 (Friday)	57,102	USD 955,316	USD 955,316	-175	USD 38,884	USD 16.73	USD 16
2024-11-07 (Thursday)	57,277	USD 916,432	USD 916,432	0	USD -3,437	USD 16	USD 16.06
2024-11-06 (Wednesday)	57,277	USD 919,869	USD 919,869	0	USD 36,085	USD 16.06	USD 15.43
2024-11-05 (Tuesday)	57,277	USD 883,784	USD 883,784	0	USD 16,610	USD 15.43	USD 15.14
2024-11-04 (Monday)	57,277	USD 867,174	USD 867,174	0	USD 18,902	USD 15.14	USD 14.81
2024-11-01 (Friday)	57,277	USD 848,272	USD 848,272	0	USD 33,793	USD 14.81	USD 14.22
2024-10-31 (Thursday)	57,277	USD 814,479	USD 814,479	0	USD -6,300	USD 14.22	USD 14.33
2024-10-30 (Wednesday)	57,277	USD 820,779	USD 820,779	0	USD -37,803	USD 14.33	USD 14.99
2024-10-29 (Tuesday)	57,277	USD 858,582	USD 858,582	0	USD -77,324	USD 14.99	USD 16.34
2024-10-28 (Monday)	57,277	USD 935,906	USD 935,906	0	USD 22,338	USD 16.34	USD 15.95
2024-10-25 (Friday)	57,277	USD 913,568	USD 913,568	0	USD 5,728	USD 15.95	USD 15.85
2024-10-24 (Thursday)	57,277	USD 907,840	USD 907,840	0	USD -234,263	USD 15.85	USD 19.94
2024-10-23 (Wednesday)	57,277	USD 1,142,103	USD 1,142,103	0	USD -65,296	USD 19.94	USD 21.08
2024-10-22 (Tuesday)	57,277	USD 1,207,399	USD 1,207,399	0	USD 23,483	USD 21.08	USD 20.67
2024-10-21 (Monday)	57,277	USD 1,183,916	USD 1,183,916	-175	USD -27,172	USD 20.67	USD 21.08
2024-10-18 (Friday)	57,452	USD 1,211,088	USD 1,211,088

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of NTLA by Blackrock for IE00BDZVHG35

Show aggregate share trades of NTLA

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-04-23 BUY 172 8.090* 11.41
2025-04-10 SELL -1,376 6.770* 11.81 Profit of 16,257 on sale
2025-04-08 SELL -172 6.280* 11.93 Profit of 2,052 on sale
2025-04-07 SELL -172 6.540* 12.00 Profit of 2,063 on sale
2025-04-04 SELL -865 6.630* 12.06 Profit of 10,430 on sale
2025-04-01 BUY 708 6.655* 12.18
2025-03-31 SELL -519 7.110* 12.24 Profit of 6,354 on sale
2025-03-21 BUY 3,042 9.000* 12.53
2025-03-14 SELL -2,624 9.140* 12.76 Profit of 33,490 on sale
2025-03-07 SELL -326 10.350* 13.00 Profit of 4,239 on sale
2025-03-04 SELL -163 9.095* 13.17 Profit of 2,147 on sale
2025-02-25 BUY 326 10.710* 13.41
2025-02-19 SELL -162 12.280* 13.51 Profit of 2,189 on sale
2025-02-13 BUY 486 9.640* 13.74
2025-02-12 BUY 162 9.510* 13.83
2025-02-11 BUY 648 9.210* 13.93
2024-12-30 SELL -5,493 11.410* 15.51 Profit of 85,200 on sale
2024-11-18 SELL -2,625 14.170* 16.51 Profit of 43,344 on sale
2024-11-08 SELL -175 16.730* 16.49 Profit of 2,885 on sale
2024-10-21 SELL -175 20.670* 0.00
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-04-23	BUY	172	8.090*	11.41
2025-04-10	SELL	-1,376	6.770*	11.81 Profit of 16,257 on sale
2025-04-08	SELL	-172	6.280*	11.93 Profit of 2,052 on sale
2025-04-07	SELL	-172	6.540*	12.00 Profit of 2,063 on sale
2025-04-04	SELL	-865	6.630*	12.06 Profit of 10,430 on sale
2025-04-01	BUY	708	6.655*	12.18
2025-03-31	SELL	-519	7.110*	12.24 Profit of 6,354 on sale
2025-03-21	BUY	3,042	9.000*	12.53
2025-03-14	SELL	-2,624	9.140*	12.76 Profit of 33,490 on sale
2025-03-07	SELL	-326	10.350*	13.00 Profit of 4,239 on sale
2025-03-04	SELL	-163	9.095*	13.17 Profit of 2,147 on sale
2025-02-25	BUY	326	10.710*	13.41
2025-02-19	SELL	-162	12.280*	13.51 Profit of 2,189 on sale
2025-02-13	BUY	486	9.640*	13.74
2025-02-12	BUY	162	9.510*	13.83
2025-02-11	BUY	648	9.210*	13.93
2024-12-30	SELL	-5,493	11.410*	15.51 Profit of 85,200 on sale
2024-11-18	SELL	-2,625	14.170*	16.51 Profit of 43,344 on sale
2024-11-08	SELL	-175	16.730*	16.49 Profit of 2,885 on sale
2024-10-21	SELL	-175	20.670*	0.00

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of NTLA

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-05-09	685,890	1,188	1,291,115	53.1%
2025-05-08	981,055	17,376	2,302,169	42.6%
2025-05-07	555,279	32,871	1,323,321	42.0%
2025-05-06	797,098	18,198	1,554,874	51.3%
2025-05-05	600,755	84	1,066,546	56.3%
2025-05-02	741,592	2,651	1,476,432	50.2%
2025-05-01	418,285	1,716	806,529	51.9%
2025-04-30	602,817	7,319	1,629,245	37.0%
2025-04-29	483,418	0	1,076,212	44.9%
2025-04-28	552,268	1,100	1,314,510	42.0%
2025-04-25	248,239	287	650,320	38.2%
2025-04-24	349,953	534	586,363	59.7%
2025-04-23	493,446	102	992,896	49.7%
2025-04-22	430,705	4,255	1,094,534	39.4%
2025-04-21	1,091,322	310	2,185,133	49.9%
2025-04-17	486,805	2,122	1,165,770	41.8%
2025-04-16	506,477	0	976,017	51.9%
2025-04-15	304,693	718	747,844	40.7%
2025-04-14	381,380	0	1,137,124	33.5%
2025-04-11	266,043	19,523	935,589	28.4%
2025-04-10	505,873	11,766	1,315,487	38.5%
2025-04-09	789,420	0	1,929,841	40.9%
2025-04-08	792,211	24,379	1,507,420	52.6%
2025-04-07	1,049,321	20,639	2,069,456	50.7%
2025-04-04	600,687	19,124	1,704,611	35.2%
2025-04-03	676,558	1,058	1,355,490	49.9%
2025-04-02	845,934	763	2,175,809	38.9%
2025-04-01	886,503	55,925	2,262,015	39.2%
2025-03-31	1,870,736	55,937	2,926,393	63.9%
2025-03-28	605,405	237	1,025,476	59.0%
2025-03-27	471,827	125	1,031,482	45.7%
2025-03-26	772,212	1,960	1,593,946	48.4%
2025-03-25	881,403	513	1,506,361	58.5%
2025-03-24	290,455	96	832,897	34.9%
2025-03-21	506,436	169	1,013,464	50.0%
2025-03-20	701,952	10	1,298,779	54.0%
2025-03-19	352,253	0	784,425	44.9%
2025-03-18	563,198	970	1,099,041	51.2%
2025-03-17	462,581	200	1,176,053	39.3%
2025-03-14	485,074	56	807,654	60.1%
2025-03-13	390,239	231	732,195	53.3%
2025-03-12	251,416	1,583	606,356	41.5%
2025-03-11	476,583	339	951,198	50.1%
2025-03-10	491,675	330	1,080,179	45.5%
2025-03-07	357,370	7,327	1,216,795	29.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE